abilify aripiprazole 2mg tablet blister pack
otsuka australia pharmaceutical pty ltd - aripiprazole, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose; hyprolose; colour - - abilify is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. - acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate; - maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.
samsca tablet 15mg
otsuka pharmaceuticals (singapore) pte. ltd. - tolvaptan - tablet - tolvaptan 15mg
abilify oral solution 1mgml
otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - solution - aripiprazole 1.0 mg/ml
abilify tablet 2mg
otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - tablet - aripiprazole 2mg
dextran 40 (10 %w/v) intr.infusion & glucose 5 % b.p.
otsuka egypt - infusion - 10 %
dextran 40 10 % in glucose 5% i.v.infusion b.p 2003
otsuka egypt - infusion
dextran 70 6% w/v glucose 5% i.v.infusion b.p 2003
otsuka egypt - infusion
dextrose 5% in ringer i.v.infusion
otsuka egypt - infusion
dextrose 5% in ringer i.v.infusion
otsuka egypt - infusion
dextrose 5 % & sodium chloride 0.45 % inj. u.s.p 25
otsuka egypt - injection